Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
WISTUBA, IGNACIO IVAN
One or more keywords matched the following items that are connected to WISTUBA, IGNACIO IVAN
Item TypeName
Academic Article Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers.
Concept Genes, erbB-2
Concept Genes, erbB-1
Academic Article Intratumoral epiregulin is a marker of advanced disease in non-small cell lung cancer patients and confers invasive properties on EGFR-mutant cells.
Academic Article Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitors.
Academic Article ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.
Academic Article EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients.
Academic Article High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor.
Academic Article Molecular pathogenesis of early-stage non-small cell lung cancer and a proposal for tissue banking to facilitate identification of new biomarkers.
Academic Article Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.
Academic Article Molecular biology, genomics, and proteomics in bronchioloalveolar carcinoma.
Academic Article Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.
Academic Article Lung cancer preneoplasia.
Academic Article Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas.
Academic Article An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.
Academic Article Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trial.
Academic Article Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.
Academic Article Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.
Academic Article Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience.
Search Criteria
  • Genes erbB